
With RFK Jr. in Charge, Insurers Aren't Saying If They'll Cover Vaccines for Kids If Government Stops Recommending Them
For 60 years ACIP has provided vaccine guidance to the Centers for Disease Control and Prevention (CDC), including on the timing and dosage of childhood immunizations. Insurers are required to cover the cost of most jabs on the recommended schedule for children. On Wednesday June 25, ACIP announced it would review the schedule, just weeks after health secretary and longtime anti-vaccine activist Robert F. Kennedy Jr. replaced the entire committee with his own appointees.
When WIRED then asked 21 of the country's largest health insurance groups whether they would stop providing cost-free coverage of current routine immunizations in the event ACIP stops recommending them, only Blue Shield of California—a company in the Blue Cross Blue Shield Association—confirmed it would.
'As a payer our role is to ensure ongoing coverage and access to preventive, evidence-based care, including immunizations,' says company spokesperson Mark Seelig. 'Therefore, Blue Shield of California is committed to maintaining coverage of immunizations. The decision on whether to receive a vaccine is between our member and their provider.'
Other large insurers, including UnitedHealthcare (which provides coverage for 50 million people), Cigna, Kaiser Permanente, Anthem, Humana, and Centene Corporation, did not respond to requests for comment. Blue Cross Blue Shield of Michigan said it had no comment.
Most insurers that did respond said they were keeping an eye on developments in Washington, without indicating whether they would or would not cover vaccines dropped from the recommended schedule.
'Vaccines play an important role in the prevention of more serious illnesses,' says Phil Blando, a spokesperson at CVS Health, which owns the insurer Aetna. 'We are monitoring any changes the federal government makes to vaccination guidance and eligibility and will evaluate whether coverage adjustments are needed.'
Highmark Inc., part of the Blue Cross Blue Shield Association, operating in Pennsylvania, Delaware, West Virginia, and New York, is also waiting to see what decision ACIP reaches. 'We are closely monitoring the evolving vaccine discussions occurring in Washington, DC. Various vaccines and immunizations are covered under Highmark's member benefits, with any future coverage considerations to be evaluated as more information becomes available,' says spokesperson Aaron Billger.
Bryan Campen, of Health Care Service Corporation—the licensee of Blue Cross Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma, and Texas—notes that no changes have yet been made to the vaccines ACIP recommends or the company's vaccine coverage, but says that the company will 'continue to monitor any activity that may impact preventive care recommendations and will communicate any changes to recommendations that may impact standard coverage of preventive services.'
Insurers had an eye on changes in ACIP guidance even before the committee announced it would revisit the schedule. 'As we navigate an evolving health care landscape, maintaining robust immunization coverage continues to be a top priority for protecting both individual and community health,' the industry's trade association, AHIP, said in a June 24 statement, the day before ACIP's announcement.
'We are committed to ongoing coverage of vaccines to ensure access and affordability for this respiratory virus season,' the statement continued. 'We encourage all Americans to talk to their health care provider about vaccines.'
ACIP made headlines in early June when RFK Jr. fired all 17 of its members and replaced them with eight new appointees. (The HHS secretary appoints the committee's members, but conventionally they serve fixed 4-year terms.) These new appointees include Retsef Levi, who has stated—in the face of scientific consensus—that mRNA vaccines are deadly, and Robert Malone, who routinely shares articles about supposed links between cancer and the Covid vaccine, which no credible research has found to exist. Neither Levi nor Malone replied to a request for comment.
Michael A. Ross, another recently appointed committee member, resigned from ACIP during a review of his financial holdings, the New York Times reported on June 24. When introducing his new ACIP appointees in a post on X earlier in June, RFK Jr. had described Ross as a faculty member at George Washington and Virginia Commonwealth universities—but spokespeople for the universities told NBC News4 that Ross had not taught at either in years. Ross did not reply to a request for comment.
The committee made news again on June 25 when, during its first meeting of the year, it announced it would form a working group to review the recommended immunization schedule for children and teens.
'The number of vaccines that our children and adolescents receive today exceed what children in most other developed nations receive, and what most of us in this room received when we [were] children,' ACIP chair Martin Kulldorff said during the meeting.
He noted that the group would examine the 'cumulative effect' of the recommended vaccine schedule, including interactions between vaccines, the total number of vaccines given, their timing, and recipients' exposure to vaccine ingredients.
But the process for adding vaccines to the schedule is already rigorous. Before a vaccine can receive FDA licensure, its manufacturer must prove it does not negatively affect the safety or immune response of other vaccines administered at the same time on the schedule, says Paul Offit, director of the Children's Hospital of Philadelphia's Vaccine Education Center.
In addition, 'the notion that these vaccines are somehow weakening your immune system or overwhelming your immune system is fanciful,' Offit says. Today, children are exposed to fewer viral or bacterial proteins in the first few years of the vaccine schedule than those in earlier generations. When Offit's parents received the smallpox vaccine, they were exposed to 200 proteins in a single shot. In contrast, the measles vaccine only contains 10.
During the meeting, Kulldorff repeated claims he made in 2024 that he was fired from Harvard because he refused to get the Covid vaccine; he and Malone have also each served as paid expert witnesses in two separate suits against Merck over the safety of the company's HPV vaccine and its mumps vaccine, respectively. Kulldorff did not reply to a request for comment.
The American Academy of Pediatrics (AAP) did not send representatives to last week's ACIP meeting, as it typically does. According to Academy president Susan Kressly, this was because the AAP believes the vaccine recommendation process lost credibility when its original membership was gutted by Kennedy.
'We won't lend our name or our expertise to a system that is being politicized at the expense of children's health,' Kressly said in a video posted online before the meeting was set to begin. The AAP did not reply to a request for comment about the video.
The most recent child immunization schedule that the AAP endorses, from November 2024, is posted on the AAP website. A newer one, posted on the CDC site, has already changed recommendations. It no longer lists as 'routine' Covid vaccines for children under 18 who are not immunocompromised, but instead lists them under vaccines recommended for 'shared clinical decision-making,' informed by 'personal preference and circumstances.' The change should not affect insurance coverage.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CNN
an hour ago
- CNN
U.S. House takes up Trump Agenda bill
The House takes up the revised Senate version of President Trump's sweeping domestic agenda bill, which passed the Senate on Tuesday by the slimmest of margins. CNN Political Analyst and Historian Leah Wright Rigueur says if the bill becomes law, people will remember Donald Trump as the President who increased the national debt and took away people's healthcare.
Yahoo
an hour ago
- Yahoo
This Coffee Swap Could Help Protect Your Eyes as You Age
If you love waking up with a morning java, you're familiar with the quick energy boost you get from consuming caffeine. But enjoying a regular cup of joe can do more than just perk you up: A new study suggests coffee can affect your vision too. Here we break down what the study reveals about the popular drink and the risk of age-related macular degeneration (AMD)—including the simple swap that might help ward off vision loss as we age. As we get older, the likelihood of developing eye diseases increases. One condition in particular to be aware of is dry age-related macular degeneration. 'Dry age-related macular degeneration is a condition that happens as you age and can lead to vision loss [especially in your central vision] or blindness,' explains Hunter Cherwek, MD, Ophthalmologist & VP of Clinical Services and Technologies at Orbis International. This is opposed to wet AMD, which is a more severe and less common form of the eye condition. 'The macula is the most sensitive part of the retina (the back of the eye) and is responsible for crisp, clear vision,' Dr. Cherwek says. 'Dry AMD is the most common form of the condition and occurs when a film grows on the retina, which causes vision distortions' or blurred vision. (See more AMD symptoms to watch for here.) If you've never had vision problems or don't have a genetic predisposition forAMD, you may be wondering how relevant the condition could be to you. But it's more common than you may realize. 'This is an incredibly important topic for everyone because it is one of the leading causes of irreversible vision loss and blindness around the world in people over the age of 60,' says Dr. Cherwek. If you have a particularly busy schedule, you may find yourself reaching for instant coffee more often than not. But when it comes to this type of brew, new research suggests it may be wise to pay attention to how much you consume in order to protect your eye health. In a new Food Science & Nutrition study, researchers found that consumption of instant coffee was associated with a nearly seven-fold increased risk of developing dry age-related macular degeneration. Ground coffee and decaf coffee did not show the same association in the study. So what is it about instant coffee in particular that could affect your vision? Meenal Agarwal, OD, a board-certified optometrist and leading authority on the eye-brain connection at Dr. Meenal Agarwal & Associates, says its processing could play a role. 'Instant coffee undergoes more intense processing, often at higher temperatures, which can produce harmful byproducts like acrylamide, a compound linked to oxidative stress and inflammation,' says Dr. Agarwal. 'These processes strip away some beneficial compounds found in brewed coffee, possibly harming tissues like the retina.' If you love instant coffee, you may not need to toss out your stash just yet. 'It's early to recommend avoiding instant coffee altogether based solely on this study,' says Dr. Agarwal, who cautions that more research is still needed. However, experts agree that if you're prone to developing AMD due to family history or other risk factors (such as being over age 50, smoking or having high blood pressure), simply replacing instant coffee with ground coffee could be a smart move. 'If you have a family history of macular degeneration, it might be worth considering switching from instant coffee to brewed coffee, but I encourage you to bring this up with an eye doctor who is familiar with your case and can give you more specific recommendations,' says Dr. Cherwek. Dr. Agarwal had the same advice for those who may be more likely to develop AMD. 'It's smart to minimize potential risks. I'd recommend limiting instant coffee, especially daily use, and opting for brewed or decaf versions,' says Dr. Agarwal. 'You don't need to give up coffee altogether, but it's worth being mindful about your choices and making positive lifestyle changes.' In addition to changing how you brew your daily cup of coffee, experts suggest other helpful strategies to help ward off AMD and protect your vision. 'The most important step someone can take is to stop smoking—it's extremely damaging to eye health and significantly increases the likelihood of developing AMD,' says Dr. Cherwek. (Discover more macular degeneration self-care tips here.) Although diet and weight may not seem directly related to eye health, they're important to consider. 'In addition, maintaining a healthy diet and managing your weight are essential,' says Dr. Cherwek. 'AMD was one of the first retinal diseases where dietary changes were shown to help prevent vision loss. Today, we have a strong body of evidence showing that lifestyle factors like diet and weight management play a critical role in lowering the risk of this disease.' Dr. Agarwal also recommends the following for lowering AMD risk: Annual eye exams A diet rich in leafy greens Omega-3s Colorful fruits Wearing 100% UVA/UVB protection or UV400 sunglasses Regular exercise Considering an eye supplement (your eye doctor can recommend specific ones) Keep scrolling for more eye health stories! Castor Oil for Dry Eyes Relieved One Woman's Discomfort When Nothing Else Worked Can Your Vision Predict Your Dementia Risk? Research Suggests It Can Burning Eyes? 3 Common Causes and Fast-Acting Home Remedies This content is not a substitute for professional medical advice or diagnosis. Always consult your physician before pursuing any treatment plan.
Yahoo
an hour ago
- Yahoo
Healthcare stocks plummet on Medicaid cuts, Apple upgraded
Healthcare insurer stocks, like UnitedHealth (UNH), Centene (CNC), and Oscar Health (OSCR), tumble as policy changes threaten the US government's Medicaid spending. Apple (AAPL) stock was upgraded to Hold from Underperform by Jefferies, highlighting potential upside for the June quarter. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. Right, time for some of today's trending tickers. We're watching Healthcare Insurance stocks, as well as Apple. First up, Healthcare Insurance is plunging at the announcement of severe Medicaid cuts in the Senate's version of Trump's big, beautiful bill. Centene appears to be the biggest loser today, but United Healthcare, Oscar are among some of the others, also seeing their shares plummet. JP Morgan downgrading Centene at the news, the insurer is pulling its full-year guidance for insurance plans sold on the Affordable Care Act exchange. Oscar Health receiving a downgrade from Raymond James and an underweight rating in newly initiated coverage by Barclays. So Centene, Barbara, they withdrew their financial guidance for 2025. They say earnings will fall short of expectations. Stock gets crushed. Your thoughts on that and maybe the broader sector as well. Well, clearly there was some nervousness today. Yeah, well, I think the stocks deserve to be crushed, given the percentage of revenues they have for Medicaid and it looks like, you know, it's going back to the tax bill's going back to the House, but Medicaid is going to be cut. And so the ramifications are going to be long-lasting for these companies. The question is, I think in other names like United Healthcare was down on this. United Healthcare maybe has 15% in Medicaid and United has its own issues. You know, but that's one that probably could be bought on any weakness here. But Centene, you know, the downgrade, I think, is deserved. It's probably going to go lower, people will stand back. So I think they're not buyable right now. At some point, they probably will be when it's really thoroughly discounted. There's some light at the end of the tunnel, but that may have to wait till another administration. Avoid for now. Yes. All right. Well, next up, Jeffries upgrading Apple from underperform to hold at possible upside for the company's third quarter. New data highlighting a 15% growth in global iPhone volumes in April and May with Chinese demand after discounting, pushing at 12% growth in March. Stemming from this, Jeffries raising its Q3 outlook for the technology and software manufacturer, with an emphasis on 9% growth, as opposed to the previous 1% forecast. So Jeffries does go to a hold, Barbara. They say Q3 could keep Apple stable in the near term. They say, we believe tariffs driven pulling tariffs driving pulling demand and share recovery in China would drive June quarter revenue EPS growth, they're saying of around 8 and 10%. They expect only flat iPhone unit growth though, in the second half. Average target on the street now's around 227. Stock is down around 15% so far this year. Right, but it's up today in a big way and I think that was the important news because as you know, they have sort of blown the AI introduction. People are waiting for that. I think it's really hurt their sales with the new models because you try to use Siri, you know, which is their their voice-enabled AI and it really doesn't work that well. You know, compared to a ChatGPT, you can go get that. So what the news today was that they might be partnering with Open AI, you know, with another outside vendor, which would be smart not to do it inside. And that's why the stock was up usually, and could probably keep running from here because so much is I think people are holding off on that. And we have to remember the big part of the Apple story is that 25% of the revenues are from services and that keeps climbing. And that's their high margin business. And that's where you have what, 2.3 billion active users, you know, and that keeps climbing. So I think Apple is probably has a little more room to run here. Uh to your point, I did see analysts saying, Barbara, when that that news crossed, that maybe they decide to partner with OpenAI or Anthropic, there were at least some on the streets saying, you know, that would be that would be a smart bridge until they can start relying on their in-house technology. Yeah. I think it would be because they haven't been able to figure it on their own and they brought in a high-level guy and that sort of they just keep missing deadline after deadline, so they have to do something. You know, because they're really falling behind here.